Exploring new ways to deliver drugs to the brain.
Official title: Drug Delivery to the Brain: Emerging Modalities
Funded at Keystone Symposia · NIH-11074359 · Data updated 2026-11-12
This study is all about a conference where experts are sharing new ideas on how to get medicines directly to the brain, which is really important for helping people with conditions like Alzheimer's and brain tumors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keystone Symposia NIH-funded |
| Lab location | 1 site (Silverthorne, United States) |
| Project start | January 3, 2025 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $15,400 |
| NIH project number | 1R13NS141587-01 |
| Project ID | NIH-11074359 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with neurodegenerative diseases, brain tumors, or other conditions requiring improved drug delivery to the brain would be ideal candidates.
✕Less likely to help
Patients with conditions unrelated to brain diseases or those who do not require advanced drug delivery methods may not benefit from this research.
What this research studies
This research focuses on a conference that brings together experts to discuss innovative methods for delivering treatments directly to the brain. It aims to address the challenges of getting drugs past the blood-brain barrier, which is crucial for treating various brain diseases, including Alzheimer's and brain tumors. Attendees will share the latest scientific advancements and clinical trial results, which could lead to improved therapies for patients with neurodegenerative diseases and other brain disorders.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from serious brain conditions.
How similar studies have gone: Previous conferences and research have shown promise in developing new drug delivery methods, indicating a growing interest and potential for breakthroughs in this area.
Where this research is happening
-
Keystone Symposia
Silverthorne, United States Active
Researchers
- Principal investigator: Sheppard, Terry L. — Keystone Symposia
- Study coordinator: Sheppard, Terry L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.